Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

Share Price is delayed by 15 minutes
Get Live Data
23.50    0.00 (0.00%)
Bid:
23.00
Ask:
24.00
Spread: 1.00 (4.348%)
Market Cap: £11.19m
PEN Live PriceLast checked at - London Stock Exchange

Intraday Pennant International Share Chart

Trading Update

20 Jan 2022 07:00

RNS Number : 0240Z
Pennant International Group PLC
20 January 2022
 

 

FOR IMMEDIATE RELEASE 20 January 2022

PENNANT INTERNATIONAL GROUP PLC

Trading Update

 

 

Pennant International Group plc (AIM:PEN) ("Pennant", the "Group" or "Company"), a leading global provider of training technology and integrated product support solutions, issues the following trading update for the year ended 31 December 2021 ("FY21"). The Company expects to publish its full-year results during May 2022.

 

A preliminary unaudited assessment of the Group's trading for FY21 indicates:

 

· revenues of circa £16 million;

· loss before interest, taxation and amortisation of circa £0.6 million;

· net debt at year-end of £3.6 million;

· three-year order book at year-end of £22 million, of which £10 million is scheduled for delivery in 2022.

 

As expected, trading improved in the second half of FY21 (with the Group generating positive EBITA of circa £0.4 million for the period 1 July to 31 December) albeit the improvement was lower than budgeted as a result of two material factors, detailed below.

 

MTE Programme

 

The challenges associated with the MTE programme were previously highlighted in the Interim Results announcement of 22 September 2021 (and included supply chain issues, residual Covid impacts, global shortages and engineering complexity).

 

The build of the MTE devices is now largely complete, with customer acceptance testing having commenced in November 2021.

 

The testing process was temporarily paused before year-end, however, testing has now re-commenced, with two of the four training devices scheduled for delivery to site in February 2022.

 

The programme will, accordingly, be marginally extended; management anticipates that all devices will be delivered during the first half of 2022. Delivery of the devices will enable Pennant to invoice remaining cash milestones totalling circa £2 million.

 

In light of this extension, and to ensure the necessary resources to deliver and finally 'close off' this contract, the Board has prudently increased internal programme budgets (including a cost allowance to deal with any remaining risks) which is fully taken into account within the year-end position.

 

Contract award timing

 

Pipeline conversion in the second half of FY21 proceeded in line with the Group's expectations with one exception: a software and services contract with a new customer in the commercial aviation sector was slightly delayed. The contract had been expected to be awarded to Pennant before year-end but will now fall into the current year.

 

The contract is worth USD$1.1 million in the first year (and USD$1.8 million overall); the sale of software licences under the contract had been budgeted to contribute to the Group's performance for FY21. The terms of the contract have now been agreed and it is in the process of being finalised and signed.

 

Commenting on the Outlook for 2022, Pennant Group CEO, Phil Walker said:

 

"2021 was a challenging year for Pennant given the continued impact of the Covid-19 pandemic on our business sector and the wider global economy.

 

"It is therefore pleasing that momentum has started to build again in our core product offerings and pipeline of new business. The Group continues to focus on its strategic objective of increasing the proportion of revenues which derive from software and services which is intended to deliver significant growth over the medium-term.

 

"Bid activity is increasing across the Group, and the Board remains very confident of the award of the 'Major Programme' within the first quarter of the year.

 

"The Group remains well placed to capture the many opportunities which lie ahead and accordingly, the Board views prospects for 2022 with increasing confidence and looks forward to reporting a significantly improved performance for the current year."

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

Enquiries:

 

Pennant International Group plc

www.pennantplc.co.uk

Philip Walker, CEO

David Clements, Commercial & Risk Director

+44 (0) 1452 714 914

 

 

WH Ireland Limited (Nomad and Broker)

www.whirelandcb.com

Mike Coe

Sarah Mather

+44 (0) 20 7220 1666

 

 

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann

Tom Cooper

+44 (0)20 7933 8780

Mob: +44 (0)7768 807631

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKCBDNBKBADD
Date   Source Headline
4th Jun 20267:00 amRNS-RLaunch of Auxilium Phase 3
20th May 20263:18 pmRNSHolding(s) in Company
19th May 20267:20 amRNS-R1st conversion services contract & Siemens update
14th May 20267:00 amRNSDirector dealing
13th May 20267:00 amRNSGrant of Options
11th May 20267:00 amRNSTraining Systems Contract Win
8th May 202611:56 amRNSResult of AGM
21st Apr 20262:05 pmRNSHolding(s) in Company
1st Apr 20262:54 pmRNSNotice of AGM & Posting of Accounts
31st Mar 20265:00 pmRNSTotal Voting Rights
26th Mar 20267:00 amRNSIssue of Equity
23rd Mar 20267:00 amRNSFinal Results & Notice of Investor Presentation
2nd Feb 20267:00 amRNSTraining Systems Contract Win
19th Jan 20267:00 amRNSTrading & Strategy Update, Notice of Results
15th Jan 20267:00 amRNSDirectorate change
12th Dec 20253:34 pmRNSDirector Dealing
1st Dec 20251:36 pmRNSDirector Dealing
27th Nov 20259:40 amRNSHolding(s) in Company
25th Nov 202512:40 pmRNSGenFly Contract Award - valued at up to £5.75m
24th Oct 202511:15 amRNSHolding(s) in Company
21st Oct 20257:00 amRNSShareholder Loan
8th Oct 202510:36 amRNSContract wins
1st Oct 20259:39 amRNSTotal Voting Rights
25th Sep 202512:59 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSSubscription update and closing & TVR
16th Sep 20257:01 amRNSProposed Underwritten Subscription to raise £1.25m
16th Sep 20257:00 amRNSInterim Results, Analyst Briefing & Investor Pres
14th Aug 20257:00 amRNSChange of Adviser
11th Aug 20253:01 pmRNSHolding(s) in Company
8th Aug 20257:00 amRNSTrading Update & Notice of Results
14th Jul 20257:00 amRNSGlobal Partner Appointed & Auxilium Presentation
3rd Jul 20257:00 amRNSBusiness Update
6th Jun 20251:08 pmRNSResult of AGM
8th May 202512:30 pmRNSNotice of AGM & Posting of Accounts
24th Apr 20257:00 amRNSFinal Results, Analyst Briefing & Investor Pres
9th Apr 20257:00 amRNSGenFly Contract Update
8th Apr 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
7th Apr 20257:00 amRNSProperty Disposal Programme Update
11th Mar 20252:25 pmRNSHolding(s) in Company
24th Feb 20257:00 amRNSProperty Disposal Programme Update
3rd Feb 20251:41 pmRNSDirector Dealings
16th Dec 202410:49 amRNSHolding(s) in Company
12th Dec 20247:00 amRNSAward of Options
10th Dec 20247:00 amRNSTrading Statement, Business Update & Investor Pres
20th Nov 20247:00 amRNSAppointment of CFO
14th Nov 20242:47 pmRNSHolding(s) in Company
6th Nov 20244:34 pmRNSHolding(s) in Company
23rd Oct 20243:56 pmRNSContracts Update
22nd Oct 20245:55 pmRNSHolding(s) in Company
10th Oct 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.